221 related articles for article (PubMed ID: 18037964)
1. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
[TBL] [Abstract][Full Text] [Related]
2. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
Archangelo LF; Gläsner J; Krause A; Bohlander SK
Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
[TBL] [Abstract][Full Text] [Related]
3. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
[TBL] [Abstract][Full Text] [Related]
4. CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.
Mulaw MA; Krause A; Deshpande AJ; Krause LF; Rouhi A; La Starza R; Borkhardt A; Buske C; Mecucci C; Ludwig WD; Lottaz C; Bohlander SK
Leukemia; 2012 May; 26(5):1012-9. PubMed ID: 22064352
[TBL] [Abstract][Full Text] [Related]
5. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
[TBL] [Abstract][Full Text] [Related]
6. Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.
Suzuki M; Yamagata K; Shino M; Aikawa Y; Akashi K; Watanabe T; Kitabayashi I
Cancer Sci; 2014 Mar; 105(3):315-23. PubMed ID: 24397609
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides.
Silliman CC; McGavran L; Wei Q; Miller LA; Li S; Hunger SP
Leukemia; 1998 Sep; 12(9):1404-10. PubMed ID: 9737689
[TBL] [Abstract][Full Text] [Related]
8. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10.
de Bruijn DR; dos Santos NR; Thijssen J; Balemans M; Debernardi S; Linder B; Young BD; Geurts van Kessel A
Oncogene; 2001 May; 20(25):3281-9. PubMed ID: 11423977
[TBL] [Abstract][Full Text] [Related]
9. Dual-color split signal fluorescence in situ hybridization assays for the detection of CALM/AF10 in t(10;11)(p13;q14-q21)-positive acute leukemia.
La Starza R; Crescenzi B; Krause A; Pierini V; Specchia G; Bardi A; Nieddu R; Ariola C; Nanni M; Diverio D; Aventin A; Sborgia M; Martelli MF; Bohlander SK; Mecucci C
Haematologica; 2006 Sep; 91(9):1248-51. PubMed ID: 16956826
[TBL] [Abstract][Full Text] [Related]
10. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Sun L; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Mao C; Vassilev A; Reaman GH; Uckun FM
Clin Cancer Res; 1999 Aug; 5(8):2112-20. PubMed ID: 10473095
[TBL] [Abstract][Full Text] [Related]
11. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L.
Okada Y; Jiang Q; Lemieux M; Jeannotte L; Su L; Zhang Y
Nat Cell Biol; 2006 Sep; 8(9):1017-24. PubMed ID: 16921363
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
Deshpande AJ; Cusan M; Rawat VP; Reuter H; Krause A; Pott C; Quintanilla-Martinez L; Kakadia P; Kuchenbauer F; Ahmed F; Delabesse E; Hahn M; Lichter P; Kneba M; Hiddemann W; Macintyre E; Mecucci C; Ludwig WD; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
Cancer Cell; 2006 Nov; 10(5):363-74. PubMed ID: 17097559
[TBL] [Abstract][Full Text] [Related]
13. Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein.
Liu H; Chen B; Xiong H; Huang QH; Zhang QH; Wang ZG; Li BL; Chen Z; Chen SJ
Oncogene; 2004 Apr; 23(19):3385-94. PubMed ID: 15077184
[TBL] [Abstract][Full Text] [Related]
14. Monocytic leukemia with CALM/AF10 rearrangement showing mediastinal emphysema.
Nakamura F; Maki K; Arai Y; Nakamura Y; Mitani K
Am J Hematol; 2003 Feb; 72(2):138-42. PubMed ID: 12555219
[TBL] [Abstract][Full Text] [Related]
15. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts.
Narita M; Shimizu K; Hayashi Y; Taki T; Taniwaki M; Hosoda F; Kobayashi H; Nakamura H; Sadamori N; Ohnishi H; Bessho F; Yanagisawa M; Ohki M
Br J Haematol; 1999 Jun; 105(4):928-37. PubMed ID: 10554802
[TBL] [Abstract][Full Text] [Related]
16. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
Conway AE; Scotland PB; Lavau CP; Wechsler DS
Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
[TBL] [Abstract][Full Text] [Related]
17. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.
Dreyling MH; Martinez-Climent JA; Zheng M; Mao J; Rowley JD; Bohlander SK
Proc Natl Acad Sci U S A; 1996 May; 93(10):4804-9. PubMed ID: 8643484
[TBL] [Abstract][Full Text] [Related]
18. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients.
Bohlander SK; Muschinsky V; Schrader K; Siebert R; Schlegelberger B; Harder L; Schemmel V; Fonatsch C; Ludwig WD; Hiddemann W; Dreyling MH
Leukemia; 2000 Jan; 14(1):93-9. PubMed ID: 10637482
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
